Haematologist Mitesh Borad at the Mayo Clinic in Phoenix, Arizona, and his colleagues have analysed the structure of the chimpanzee adenovirus used in the Oxford-AstraZeneca vaccine and determined that it has a strong negative charge. Molecular simulations suggest that this charge, combined with aspects of the virus’s shape, could allow…